HAYA Therapeutics wins the top prize at the TOP 100 Swiss Startup Award 2023

Bloom Science Announces Positive Topline Data from a Phase 1 Clinical Trial of BL-001, a Potential First-in-Class Therapeutic Being Developed for Both Dravet Syndrome and ALS

Auron Establishes Premier Scientific Advisory Board to Support the Advancement of its AI-Powered Platform and Pipeline Targeting Cellular Plasticity in Cancer

Focal Biosciences: new cellular reprogramming startup unveiled

Junk DNA: how the dark genome is changing RNA therapies

Megatrend Biotech: Dieser Investor kennt fünf Startups mit blendenden Aussichten

The Longevity Biotechnology Association (LBA): Defining a Longevity Biotechnology Company

Samsara Therapeutics adds eminent neurologist Professor Dame Pamela Shaw to its scientific advisory board to help accelerate ALS/MND treatment development